These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15924770)

  • 1. [Percutaneous coronary intervention combined cardiac resynchronization therapy for refractory heart failure secondary to ischemic cardiomyopathy].
    Han YL; Zang HY; Wang DM; Jing QM; Wang SL; Wang ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):17-21. PubMed ID: 15924770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effects and mortality of biventricular pacing therapy in patients with congestive heart failure].
    Wang DM; Han YL; Zang HY; Zhou WW; Jing QM; Wang ZL; Wang SL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):717-9. PubMed ID: 16188059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of cardiac resynchronization therapy for patients with refractory congestive heart failure].
    Mu HY; Lin T; Ma YO; Tang BP; Shi XK; Liu ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):878-82. PubMed ID: 20137535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
    Molhoek SG; Bax JJ; van Erven L; Bootsma M; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Apr; 93(7):860-3. PubMed ID: 15050489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.
    Lecoq G; Leclercq C; Leray E; Crocq C; Alonso C; de Place C; Mabo P; Daubert C
    Eur Heart J; 2005 Jun; 26(11):1094-100. PubMed ID: 15728648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study.
    Lenarczyk R; Kowalski O; Kukulski T; Szulik M; Pruszkowska-Skrzep P; Zielinska T; Kowalczyk J; Pluta S; Duszanska A; Sredniawa B; Musialik-Lydka A; Kalarus Z
    Europace; 2007 Sep; 9(9):762-7. PubMed ID: 17631515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.